Operating Segments (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Schedule of operating segments

	For the Years Ended December 31,
	2020			2019
Revenues
Public Health Solutions	$	2,242,078		$	3,402,014
Specialized BioTherapeutics		117,369			1,227,902
Total	$	2,359,447		$	4,629,916
Income (Loss) from Operations
Public Health Solutions	$	(435,028	)	$	153,969
Specialized BioTherapeutics		(13,610,715	)		(6,738,284	)
Corporate		(4,540,764	)		(3,956,706	)
Total	$	(18,586,507	)	$	(10,541,021	)
Amortization and Depreciation Expense
Public Health Solutions	$	21,672		$	17,507
Specialized BioTherapeutics		11,839			18,122
Corporate		28,861			18,821
Total	$	62,372		$	54,450
Other Income (Expense), Net
Specialized BioTherapeutics	$	71,974			425,785
Corporate		(10,882	)		148,968
Total	$	61,092		$	574,753
Share-Based Compensation
Public Health Solutions	$	47,453		$	36,003
Specialized BioTherapeutics		148,107			107,214
Corporate		214,373			233,122
Total	$	409,933		$	376,339

	As of December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	176,447	$	1,018,673
Specialized BioTherapeutics		147,784		41,705
Corporate		19,567,004		6,714,983
Total	$	19,891,235	$	7,775,360